PMRA GovernmentGovernment Notice 27 of 2026
Government Notice 27 of 2026 is the official PMRA identifier for “Pharmacy and Medicines Regulatory Authority (Fees and Forms) (Amendment) Regulations, 2026”. Government Notice 27 of 2026 is the official identifier PMRA uses for this instrument.
- Instrument
- Government
- Full name
- Government Notice 27 of 2026
- Category
- Registration
- Source publication
- English
- Readable HTML
- 1 language version
- Published
- 2026-03-27
- Effective
- 2026-04-01
Open a language version
Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.
Pharmacy and Medicines Regulatory Authority (Fees and Forms) (Amendment) Regulations, 2026
Complete 11-page official Gazette instrument, printed pages 183–193, made and published on 27 March 2026 and expressly effective from 1 April 2026. Regulation 2 replaces the First Schedule of the Fees and Forms Regulations, GN 9/2022; it does not repeal the whole parent or replace its Second Schedule forms. The entire new fee schedule is retained, including medical-device premises licensing/retention, device registration and retention for classes I–III, imports, inspections, advertising, general post-registration-change fee categories and all notes. Original columns and currency distinctions are preserved. The schedule does not itself define a complete device variation classification, submission procedure or review timeline. The complete 2022 parent and all 25 Second Schedule forms are retained separately as a dated amended original. Device-specific implementing requirements, later form updates and subsequent amendments remain under review.
Government Notice 27 of 2026 is the official identifier PMRA uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.